The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Serum Sex Steroids in Premenopausal Women and Breast Cancer Risk Within the European Prospective Investigation into Cancer and Nutrition (EPIC)
Abstract
BACKGROUND: Contrasting etiologic hypotheses about the role of endogenous sex steroids in breast cancer development among premenopausal women implicate ovarian androgen excess and progesterone deficiency, estrogen excess, estrogen and progesterone excess, and both an excess or lack of adrenal androgens (dehydroepiandrosterone [DHEA] or its sulfate [DHEAS]) as risk factors. We conducted a case-control study nested within the European Prospective Investigation into Cancer and Nutrition cohort to examine associations among premenopausal serum concentrations of sex steroids and subsequent breast cancer risk. METHODS: Levels of DHEAS, (Delta4-)androstenedione, testosterone, and sex hormone binding globulin (SHBG) were measured in single prediagnostic serum samples from 370 premenopausal women who subsequently developed breast cancer (case patients) and from 726 matched cancer-free control subjects. Levels of progesterone, estrone, and estradiol were also measured for the 285 case patients and 555 matched control subjects who had provided information about the day of menstrual cycle at blood donation. Conditional logistic regression models were used to estimate relative risks of breast cancer by quartiles of hormone concentrations. All statistical tests were two-sided. RESULTS: Increased risks of breast cancer were associated with elevated serum concentrations of testosterone (odds ratio [OR] for highest versus lowest quartile = 1.73, 95% confidence interval [CI] = 1.16 to 2.57; P(trend) = .01), androstenedione (OR for highest versus lowest quartile = 1.56, 95% CI = 1.05 to 2.32; P(trend) = .01), and DHEAS (OR for highest versus lowest quartile = 1.48, 95% CI = 1.02 to 2.14; P(trend) = .10) but not SHBG. Elevated serum progesterone concentrations were associated with a statistically significant reduction in breast cancer risk (OR for highest versus lowest quartile = 0.61, 95% CI = 0.38 to 0.98; P(trend) = .06). The absolute risk of breast cancer for women younger than 40 followed up for 10 years was estimated at 2.6% for those in the highest quartile of serum testosterone versus 1.5% for those in the lowest quartile; for the highest and lowest quartiles of progesterone, these estimates were 1.7% and 2.6%, respectively. Breast cancer risk was not statistically significantly associated with serum levels of the other hormones. CONCLUSIONS: Our results support the hypothesis that elevated blood concentrations of androgens are associated with an increased risk of breast cancer in premenopausal women.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Gail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334
Breast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M., Lane, D., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., et al. (2003) · JAMA · doi:10.1001/jama.289.24.3243 · Cited by 1,872
Riboli, E., Hunt, K., Slimani, N., Ferrari, P., Norat, T., Fahey, M., Charrondière, U., Hémon, B., Casagrande, C., Vignat, J., et al. (2002) · Public Health Nutrition · doi:10.1079/phn2002394 · Cited by 1,866
Self-citationThe Endogenous Hormones and Breast Cancer Collaborative Group (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.8.606 · Cited by 1,793
Breast cancer and hormone-replacement therapy: the Million Women Study
Beral, V., Banks, E., Reeves, G., & Bull, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14596-5 · Cited by 1,273
Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer Risk
Schairer, C. (2000) · JAMA · doi:10.1001/jama.283.4.485 · Cited by 1,048
Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk
Pike, M. C., Spicer, D. V., Dahmoush, L., & Press, M. F. (1993) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036102 · Cited by 1,010
Ovarian cancer and hormone replacement therapy in the Million Women Study
Beral, V. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60534-0 · Cited by 937
Labrie, F., Luu-The, V., Labrie, C., Bélanger, A., Simard, J., Lin, S.-X., & Pelletier, G. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0031 · Cited by 544
Li, C. I. (2003) · JAMA · doi:10.1001/jama.289.24.3254 · Cited by 417
Physiological importance of dehydroepiandrosterone.
Eberling, P., & Koivisto, V. A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92587-9 · Cited by 365
Oestrogen exposure and breast cancer risk
Travis, R. C., & Key, T. J. (2003) · Breast Cancer Research · doi:10.1186/bcr628 · Cited by 346
Self-citationEstrogen and antiestrogen regulation of cell cycle progression in breast cancer cells
Doisneau-Sixou, S. F., Sergio, C. M., Carroll, J. S., Hui, R., Musgrove, E. A., & Sutherland, R. L. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100179 · Cited by 333
Thomas, H., Key, T., Allen, D., Moore, J., Dowsett, M., Fentiman, I., & Wang, D. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.398 · Cited by 289
Self-citationVerkasalo, P. K., Thomas, H. V., Appleby, P. N., Davey, G. K., & Key, T. J. (2001) · Cancer Causes & Control · doi:10.1023/a:1008929714862 · Cited by 287
Self-citationZeleniuch-Jacquotte, A., Shore, R. E., Koenig, K. L., Akhmedkhanov, A., Afanasyeva, Y., Kato, I., Kim, M. Y., Rinaldi, S., Kaaks, R., & Toniolo, P. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601517 · Cited by 186
Self-citationLange, C. A., Richer, J. K., & Horwitz, K. B. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0290 · Cited by 181
A prospective study of endogenous hormones and breast cancer.
Kj, H., Aj, A., Tl, B., Longcope, C., Gb, G., & Comstock, G. W. (1994) · PubMed · Cited by 170
Chapter 8: Estrogen Receptor-Mediated Processes in Normal and Cancer Cells
Dickson, R. B., & Stancel, G. M. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024237 · Cited by 168
SEX HORMONE LEVELS IN SERUM IN RELATION TO THE DEVELOPMENT OF BREAST CANCER
WYSOWSKI, D. K., COMSTOCK, G. W., HELSING, K. J., & LAU, H. L. (1987) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114596 · Cited by 163
Progesterone Receptors in Mammary Gland Development and Tumorigenesis
Conneely, O. M., Mulac‐Jeričević, B., & Lydon, J. P. (2003) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1025952924864 · Cited by 161
Roles of androgens in the development, growth, and carcinogenesis of the mammary gland
Liao, D. J., & Dickson, R. B. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00185-6 · Cited by 158
A prospective study of estradiol and breast cancer in Japanese women.
Kabuto, M., Akiba, S., Stevens, R. G., Neriishi, K., & Land, C. E. (2000) · PubMed · Cited by 156
Estradiol and Progesterone Regulate the Proliferation of Human Breast Epithelial Cells
Foidart, J.-M., Colin, C., Denoo, X., Desreux, J., Béliard, A., Fournier, S., & Lignieres, B. D. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00042-9 · Cited by 155
Effect of transport conditions on the stability of biochemical markers in blood.
Hankinson, S. E., London, S. J., Chute, C. G., Barbieri, R. L., Jones, L. A., Kaplan, L., Sacks, F. M., & Stampfer, M. J. (1989) · Clinical Chemistry · doi:10.1093/clinchem/35.12.2313 · Cited by 137
Endogenous sex hormones and subsequent breast cancer in premenopausal women
Micheli, A., Muti, P. C., Secreto, G., Krogh, V., Meneghini, E., Venturelli, E., Sieri, S., Pala, V. M., & Berrino, F. (2004) · International Journal of Cancer · doi:10.1002/ijc.20403 · Cited by 135
Self-citationThomas, H., Key, T., Allen, D., Jw, M., Dowsett, M., Fentiman, I., & Wang, D. Y. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.183 · Cited by 108
Self-citationAndrogens and mammary growth and neoplasia
Dimitrakakis, C., Zhou, J., & Bondy, C. A. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)02979-5 · Cited by 105
Androgens and breast cancer in premenopausal women.
Secreto, G., Toniolo, P. G., Pisani, P., et al. (1989) · PubMed · Cited by 87
Self-citationRosenberg, C. R., Pasternack, B. S., Shore, R. E., Koenig, K. L., & Toniolo, P. G. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117278 · Cited by 86
Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period.
Muti, P. C., Trevisan, M., Micheli, A., Krogh, V., BOLELLI, G., Sciajno, R., & Berrino, F. (1996) · PubMed · Cited by 86
Self-citationThe premenstrual endometrial pattern of women with breast cancer.A study of progestational activity
Grattarola, R. (1964) · Cancer · doi:10.1002/1097-0142(196409)17:9<1119::aid-cncr2820170904>3.0.co;2-1 · Cited by 74
Michaud, D. S., Manson, J. E., Spiegelman, D. L., Barbieri, R. L., Sepkovic, D. W., Bradlow, H. L., & Hankinson, S. E. (1999) · PubMed · Cited by 68
Reliability of measurements of total, protein-bound, and unbound estradiol in serum.
Toniolo, P. G., Koenig, K. L., Pasternack, B. S., Banerjee, S., Rosenberg, C. R., Shore, R. E., Strax, P., & Levitz, M. (1994) · PubMed · Cited by 63
Lanari, C., & Molinolo, A. (2002) · Breast Cancer Research · doi:10.1186/bcr539 · Cited by 62
Abnormal production of androgens in women with breast cancer.
Secreto, G., & Zumoff, B. (1995) · PubMed · Cited by 59
Self-citationIncreased androgenic activity and breast cancer risk in premenopausal women.
Secreto, G., Toniolo, P. G., Berrino, F., et al. (1984) · PubMed · Cited by 58
Self-citationGrattarola, R. (1973) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)31304-1 · Cited by 56
Sex hormone-induced mammary carcinogenesis in female Noble rats: the role of androgens
Xie, B. (1999) · Carcinogenesis · doi:10.1093/carcin/20.8.1597 · Cited by 47
Viruses as possible etiologic factors in human breast cancer
Dmochowski, L. L., SEMAN, G., & Gallager, H. S. (1969) · Cancer · doi:10.1002/1097-0142(196912)24:6<1235::aid-cncr2820240629>3.0.co;2-g · Cited by 45
Wang, D. Y., Reed, M. J., Allen, D. S., Bulbrook, R. D., Thomas, B. S., Hayward, J. L., Stavola, B. L. D., Fentiman, I. S., & Brussen, J. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1180 · Cited by 43
Adrenal androgens and human breast cancer: A new appraisal
Adams, J. B. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006050720900 · Cited by 42
Secreto, G., Fariselli, G., Bandieramonte, G., Recchione, C., Dati, V., & Pietro, S. D. (1983) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(83)90389-9 · Cited by 39
Self-citationXie, B. (1999) · Carcinogenesis · doi:10.1093/carcin/20.6.1069 · Cited by 35
Plasma Adrenal Androgens and Risk of Breast Cancer in Premenopausal Women
Page, J. H., Colditz, G. A., Rifai, N., Barbieri, R. L., Willett, W. C., & Hankinson, S. E. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.1032.13.6 · Cited by 28
Antiestrogen Action of Progesterone in Breast Tissue
MAUVAIS-JARVIS, P., Kuttenn, F., & Gompel, A. (2008) · Hormone Research · doi:10.1159/000180946 · Cited by 25
Murphy, J. M., Browne, R. W., Hill, L., BOLELLI, G., Abagnato, C. A., Berrino, F., Freudenheim, J. L., Trevisan, M., & Muti, P. C. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc372_6 · Cited by 21
Self-citation
Cited by
Estrogen Carcinogenesis in Breast Cancer
Yager, J. D., & Davidson, N. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050776 · Cited by 1,862
Obesity as a Major Risk Factor for Cancer
De Pergola, G., & Silvestris, F. (2013) · Journal of Obesity · doi:10.1155/2013/291546 · Cited by 959
Diabetes mellitus and risk of breast cancer: A meta‐analysis
Larsson, S. C., Mantzoros, C. S., & Wolk, A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22717 · Cited by 875
Plottel, C. S., & Blaser, M. J. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.10.003 · Cited by 743
Adiposity and cancer risk: new mechanistic insights from epidemiology
Renehan, A. G., Zwahlen, M., & Egger, M. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3967 · Cited by 654
Metadata
- Authors
- Kaaks, R., Berrino, F., Key, T., Rinaldi, S., Dossus, L., Biessy, C., Secreto, G., Amiano, P., Bingham, S., Boeing, H., de Mesquita, H. B. B., Chang-Claude, J., Clavel-Chapelon, F., Fournier, A., van Gils, C. H., Gonzalez, C. A., Gurrea, A. B., Critselis, E., Khaw, K. T., Krogh, V., Lahmann, P. H., Nagel, G., Olsen, A., Onland-Moret, N. C., Overvad, K., Palli, D., Panico, S., Peeters, P., Quirós, J. R., Roddam, A., Thiebaut, A., Tjønneland, A., Chirlaque, M. D., Trichopoulou, A., Trichopoulos, D., Tumino, R., Vineis, P., Norat, T., Ferrari, P., Slimani, N., & Riboli, E.
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-05-18
- Volume
- 97
- Issue
- 10
- Pages
- 755-765
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2115379774
- Cited by
- 420
- References
- 50
- FWCI
- 16.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.